Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
01 1EVONIK OPERATIONS GMBH Essen DE
02 1AUROBINDO PHARMA LIMITED Hyderabad IN
03 1ESTEVE QUIMICA S.A. Barcelona ES
04 1Farmhispania, S.A. Montmeló ES
05 1GEDEON RICHTER PLC Budapest HU
06 3HETERO DRUGS LIMITED Hyderabad IN
07 1LEK PHARMACEUTICALS D.D. Ljubljana SI
08 1LUPIN LIMITED Mumbai IN
09 1MYLAN LABORATORIES LIMITED Hyderabad IN
10 1RICHTER THEMIS MEDICARE (I) PVT. LTD. Vapi IN
11 1Ranbaxy Laboratories Limited Gurgaon IN
12 1UNIMARK REMEDIES LIMITED Mumbai IN
13 1ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. Tiantai CN
14 2ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Certificate Number : R1-CEP 2004-011 - Rev 07
Status : Valid
Issue Date : 2020-12-09
Type : Chemical
Substance Number : 1120
26
PharmaCompass offers a list of Lisinopril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lisinopril manufacturer or Lisinopril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lisinopril manufacturer or Lisinopril supplier.
PharmaCompass also assists you with knowing the Lisinopril API Price utilized in the formulation of products. Lisinopril API Price is not always fixed or binding as the Lisinopril Price is obtained through a variety of data sources. The Lisinopril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-, including repackagers and relabelers. The FDA regulates L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- supplier is an individual or a company that provides L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- active pharmaceutical ingredient (API) or L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- finished formulations upon request. The L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- suppliers may include L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- API manufacturers, exporters, distributors and traders.
click here to find a list of L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP of the European Pharmacopoeia monograph is often referred to as a L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- Certificate of Suitability (COS). The purpose of a L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- to their clients by showing that a L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP has been issued for it. The manufacturer submits a L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP (COS) as part of the market authorization procedure, and it takes on the role of a L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP holder for the record. Additionally, the data presented in the L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- DMF.
A L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)- suppliers with CEP (COS) on PharmaCompass.
We have 13 companies offering L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-
Get in contact with the supplier of your choice:
